There is multi, multi, multi-billions of dollars earmarked by the drug companies.

Why?

They want to acquire up-and-coming competitors and those with valuable patents they can exploit.

For about 7 years, the drug industry has drastically underperformed the S&P 500.

However, look over my shoulder and see how this narrative could change very soon.

Every week, I send out weekly FREE tips just like this.

And, in this case, there’s a pretty obvious long-term trade that could be made once bio companies turn bullish again.

I recorded this FREE 5 minute video to share this #1 drug trade.